Home / Health / Lilly's Drug Aids Weight Loss and Sleep
Lilly's Drug Aids Weight Loss and Sleep
7 Jun
Summary
- Eli Lilly's retatrutide demonstrated success in trials.
- The drug significantly reduced sleep apnea severity.
- Retatrutide also helped alleviate knee pain.
Drugmaker Eli Lilly presented trial results for its experimental obesity drug, retatrutide, to medical professionals on Saturday. The study revealed that retatrutide not only promotes substantial weight loss but also effectively reduces the severity of obstructive sleep apnea. This dual action addresses two significant health issues experienced by many individuals struggling with weight.
Further findings from the trials indicated that retatrutide also helped alleviate knee pain, suggesting broader therapeutic applications. These comprehensive results were shared during a presentation, highlighting the drug's potential to offer multiple health benefits beyond weight management. The drugmaker's presentation focused on these encouraging outcomes for retatrutide.
